Metabolism2024Open AccessHighly Cited
Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challenges
Michail Kokkorakis, Chrysoula Boutari, Michael A. Hill et al.
128 citations2024Open Access — see publisher for license terms1 related compound
Research Article — Peer-Reviewed Source
Original research published by Kokkorakis et al. in Metabolism. Redistributed under Open Access — see publisher for license terms. MedTech Research Group provides these references for informational purposes. We do not conduct original research. All studies are the work of their respective authors and institutions.
Full Text
Full text is available at the publisher.
Read at PublisherArticle Details
| DOI | 10.1016/j.metabol.2024.155835 |
| Journal | Metabolism |
| Year | 2024 |
| Authors | Michail Kokkorakis, Chrysoula Boutari, Michael A. Hill, Vasilios Kotsis, Rohit Loomba, Arun J. Sanyal, Christos S. Mantzoros |
| License | Open Access — see publisher for license terms |
| Citations | 128 |